Global Orphan Drugs Market Research Report: Growth, Demand & Opportunities
Asia-Pacific is reshaping the global Orphan Drugs Market with a projected CAGR of 12.18% through 2035. China expanded its National Rare Disease List to 207 conditions and introduced zero-tariff import policies for designated orphan drugs. Japan's SAKIGAKE accelerated pathway and South Korea's conditional approval framework are compressing timelines for small-population therapies. India's...
0 Σχόλια 0 Μοιράστηκε 16 Views 0 Προεπισκόπηση
Comunidad EDUCA https://comunidadeduca.com